News & Analysis on Clinical Trial Services & Contract Research And Development
Rich Pharmaceuticals has selected a clinical trial site in Thailand at which it will conduct a Phase I/II trial in collaboration with the contract research organization (CRO) CMIC ASIA-PACIFIC, PTE. LTD. (CMIC).
Private equity continues to make inroads in the contract research industry with two firms set to purchase AMRI in a deal worth $21.75 per share.
Takeda has begun construction of an Irish facility to support production of its orally delivered blood cancer peptide Ninlaro (ixazomib).
Ingredients manufacturer Roquette says it will acquire Blancer’s Brazil-based excipient division, Itacel, to meet market demand.
Continuous manufacturing equipment installed at a CordenPharma French facility has reduced cycle time and cost of making a hypertriglyceridemia drug, says Acasti Pharma.